Tredje AP-fonden’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
7,998
+2,242
| +39% | +$491K | 0.01% | 264 |
|
|
2025
Q1 | $1.29M | Hold |
5,756
| – | – | 0.01% | 309 |
|
|
2024
Q4 | $1.89M | Sell |
5,756
-5,756
| -50% | -$1.89M | 0.02% | 279 |
|
|
2024
Q3 | $3.46M | Hold |
11,512
| – | – | 0.03% | 259 |
|
|
2024
Q2 | $3.79M | Sell |
11,512
-182
| -2% | -$59.9K | 0.04% | 226 |
|
|
2024
Q1 | $4.63M | Hold |
11,694
| – | – | 0.05% | 209 |
|
|
2023
Q4 | $4.12M | Sell |
11,694
-3,826
| -25% | -$1.35M | 0.05% | 226 |
|
|
2023
Q3 | $5.82M | Sell |
15,520
-1,150
| -7% | -$431K | 0.09% | 163 |
|
|
2023
Q2 | $6.38M | Sell |
16,670
-2,293
| -12% | -$877K | 0.09% | 162 |
|
|
2023
Q1 | $6.57M | Buy |
18,963
+729
| +4% | +$253K | 0.1% | 147 |
|
|
2022
Q4 | $4.29M | Buy |
18,234
+651
| +4% | +$153K | 0.07% | 193 |
|
|
2022
Q3 | $4.33M | Buy |
17,583
+14,618
| +493% | +$3.6M | 0.09% | 169 |
|
|
2022
Q2 | $897K | Hold |
2,965
| – | – | 0.02% | 307 |
|
|
2022
Q1 | $1.22M | Hold |
2,965
| – | – | 0.02% | 302 |
|
|
2021
Q4 | $1.39M | Buy |
+2,965
| New | +$1.39M | 0.03% | 301 |
|